Philippe Drevot
Clinical Development and Project Director
Pharmacist and PhD in immunology with 20 years of experience in clinical operations and development, Philippe has managed global studies in oncology and neuropediatric rare disease indications in North America, South America, South East Asia and Eastern Europe.
He manages studies from start-up to close out, including the writing of essential documents (investigators brochure, clinical trial protocol, ICF, study plans) and the management of third-party vendors.
Before joining ILife Consulting in March 2024, Philippe was Head of Clinical Operations at Lysogene.
His current responsibilities include:
​
-
Management of project resource attribution and project delivery
-
Management of Clinical Project Managers
-
Assisting biotechs with clinical development, communication, financial and operational strategies
Experience
-
Phase III Oncology – Chemotherapy and mAb (Adjuvant breast cancer, Metastatic breast cancer)
​
-
Phase II/III Neuropediatric rare disease - Gene therapy (Sanfilippo A)
​
-
Phase I/II Neuropediatric rare disease - Gene therapy (Gangliosidosis)
Meet our other team members
.png)
Marina
Iché
Founder and
CEO
.png)
Olivia
Chambrette
Human
Ressources
.png)
Tiffany
Roger
Clinical Project
Manager
.png)
Gwenaëlle
Roguet
Clinical Project
Manager
.png)
Tanja
Ouimet
Business & Strategy
Director
.png)
Lola
Rubira
Office
Manager
.png)
Ophélie
Orset
Clinical Project
Manager
.png)
Maxime
Waldron
Financial
Director
.png)
Rana
Boussi
Clinical Operations Director
.png)
Juliette
Coignard
Clinical Project
Manager
.png)
Geraldine
Freche
Administrative
Assistant
.png)
Céline
Leparquier
Clinical and Regulatory Affairs Director
.png)
Anais
Maugard
Clinical Project
Manager